Men’ s Health: Natural health approaches for better prostate health
of Benign Prostatic Hyperplasia. Int J Andol 33( 3): 475 – 88. 10. Fritschi, L., et al. 2007. Occupational Risk Factors for Prostate Cancer and Benign Prostatic Hyperplasia: a Case-Control Study in Western Australia. Occup Environ Med 64:60 – 65. 11. Fuhr, U., et al. 2006 Feb. Toxicokinetics of Acrylamide in Humans after Ingestion of a Defined Dose in a Test Meal to Improve Risk Assessment for Acrylamide Carcinogenicity. Cancer Epidemiol Biomarkers Prev 15( 2): 266 – 71. 12. Galic, J., and D. Simunovic. 2008. Prostate Disease Prevalence with Epidemiological and Hormonal Analysis in Randomly Selected Male Population in Croatia. Coll Anthropol 32( 4): 1195 – 102. 13. Hammarsten, J., et al. 1998 Mar. Components of the Metabolic Syndrome— Risk Factors for the Development of Benign Prostatic Hyperplasia. Prostate Cancer Prostatic Dis 1( 3): 157 – 62. 14. Ishani, a., et al. 2000 Dec 1. Pygeum Africanum for the Treatment of Patients with Benign Prostatic Hyperplasia: A Systematic Review and Quantitative Meta-Analysis. Am J Med 109( 8): 654 – 64. 15. Kristal, a. R., et al. 2008 Apr 15. Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol 167( 8): 925 – 34. 16. Li, J., et al. 2008 Oct. Observation on therapeutic Effects of Elongated Needle therapy on Dysuria Induced by Benign Prostatic Hyperplasia. Zhongguo Zhen Jiu 28( 10): 707 – 9. 17. Liao, S. 2001 Dec. the Medicinal Action of Androgens and Green Tea Epigallocatechin Gallate. Hong Kong Med J 7( 4): 369 – 74. 18. Ma, Z., et al. 2004 Jun. Reduction in Rat Prostate Weight by Combined Quercetin-Finasteride Treatment is Associated with Cell Cycle Deregulation. J Endocrinol 181( 3): 493 – 507. 19. Maclaughlin, B. W., et al. 2006 Dec. Effects of Homeopathic Preparations on Human Prostate Cancer Growth in Cellular and Animal Models. Integr Cancer Ther 5( 4): 362 – 72. Medline Plus: Retrieved Aug 2, 2011: Http:// Www. Nlm. Nih. Gov / Medlineplus / Ency / Article / 000381. Htm 20. Mongiu, a. K., and K. T. Mcvary. 2009 Jul. Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Obesity. Curr Urol Rep 10( 4): 247 – 53. 21. Nandeesha, H., et al. 2006. Hyperinsulinemia and Dyslipidemia in Non-Diabetic Benign Prostatic Hyperplasia. Clin Chim Acta 370( 1-2): 89 – 93. 22. Pais, P. 2010 Aug. Potency of a Novel Saw Palmetto Ethanol Extract, Spet-05, for Inhibition of 5alpha-Reductase II. Adv ther 27( 8): 555 – 63. 23. Parsons, J. K., et al. 2008. Physical Activity, Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms. Eur Urol 53( 6): 1228 – 35.
71